PCI High Potent Manufacturing
LB Bohle – 10.06.2025
Temax_Krautz

Current Edition

Current Edition

Subsection - CDMO

Examining how innovative technologies, integrated manufacturing approaches and AI are shaping manufacturing.

Continue reading

Subsection - Injectables

Exploring advances in injectable drug delivery and sterile manufacturing, designed to improve patient-centric delivery.

Continue reading

Subsection - Neurodegenerative Diseases

Exploring emerging approaches to neurodegenerative disease research and treatment.

Continue reading

Subsection - Nasal & Pulmonary

Highlighting how advances in nasal and pulmonary drug delivery, formulation, devices and analytics are enabling more complex therapies.

Continue reading

Advertisement

CPHI 2027
DDL 2026

Advertisement

Nipro August 26

Advertisement

Merxin March 2026

Advertisement

Aurisco 300×250

Advertisement

Lifecore Biomedical

TTP Ventus micropump technology enables wearable treatment for sleep apnea

TTP Ventus Ltd, a spin-out from TTP plc, created to bring disruptive new micropump technologies to market, has announced that Sommetrics Inc., is using its Disc Pump technology to enable aerSleep™, a novel negative-pressure system for the treatment of obstructive sleep apnea (OSA). Having recently received a Health Canada Medical Device License, aerSleep is now approved for marketing to patients in Canada. CE mark approval is expected Q4 2018.
 
OSA is a disorder characterised by airway collapse during sleep, causing sufferers to stop breathing temporarily. The muscles supporting soft tissues in the throat relax, allowing the tissues to close over and obstruct the airway. It is estimated that there are more than 100 million sufferers worldwide, with more than 22 million in the United States alone. The leading conventional treatment for OSA is continuous positive airway pressure (CPAP). The treatment is effective yet requires users to wear a face mask connected via a hose to a large bedside pump unit, which is often uncomfortable, disruptive, and can restrict users’ movement during sleep.
 
Sommetrics’ aerSleep applies negative external air pressure to the outside of the neck by means of a soft collar, to gently move the tissue and tongue forward and prevent airway collapse. This approach avoids the need for a face-worn mask, helping to improve user comfort.
 
Jerry Aarestad, Co-Founder, Sommetrics commented: “We had already developed prototypes by the time we met TTP Ventus and we knew that our technology worked. However, during the early stages of development, our system shared a constraint with CPAP in that it required a connection to a bedside pump via a tube. Within minutes of seeing Disc Pump we knew that we’d found the solution we needed. Our whole plan had changed.”
 
A combination of silent, vibration-free operation, compact form factor and efficiency enabled Sommetrics to integrate Disc Pump directly into the collar. This eliminated the need for a hose and beside pump, thereby offering a non-invasive and therefore tolerable solution to OSA patients.
 
Tom Harrison, Business Development Manager, TTP Ventus, commented: “Sommetrics’ aerSleep is a great example of how Disc Pump can enable genuinely disruptive products. Silent operation was critical to enabling this wearable sleep product; in other applications it’s our millisecond response time or non-pulsatile flow that bring value. We are proud to have partnered with Sommetrics to bring this ground-breaking product to market, and we hope their success will inspire other applications of our technology.”
 

Advertisement

MedPharm 16/07

Advertisement

Biopharma group march 2026

Advertisement

Silgan March 2026

Advertisement

Terumo 06/26

Advertisement

Scott Pharma – 25.03.2025

Advertisement

Bespak

Advertisement

Solstice

Advertisement

Bachem skyscraper
Tjoapack
Aptar – 08/01/2026